Botryosphaeria obtusa
Botryosphaeria obtusa is a fungal pathogen that is known to cause significant damage to a variety of plant species. It is a member of the Botryosphaeriaceae family and is commonly referred to as the black rot fungus.
Taxonomy
The fungus was first described in 1875 by Pier Andrea Saccardo, an Italian mycologist. It belongs to the Ascomycota division, the largest division of fungi, which includes more than 64,000 species. The species name obtusa refers to the blunt or rounded ends of the spores produced by the fungus.
Description
Botryosphaeria obtusa is characterized by its dark, spherical fruiting bodies that produce spores. The spores are typically hyaline and unicellular, and they are dispersed by wind or water. The fungus also produces mycelia, which are the vegetative part of a fungus, consisting of a network of fine white filaments.
Pathology
Botryosphaeria obtusa is a necrotrophic pathogen, meaning it kills host tissue and then feeds on the dead material. It is known to cause a variety of diseases in plants, including black rot in grapes, canker in apple trees, and dieback in various other plant species. The fungus enters the plant through wounds or natural openings and then spreads throughout the plant, causing necrosis of the tissue.
Management
Control of Botryosphaeria obtusa typically involves a combination of cultural practices and chemical treatments. Cultural practices include pruning infected branches and removing infected fruit. Chemical treatments include the application of fungicides. However, the fungus can develop resistance to these treatments, making management challenging.
Impact
The economic impact of Botryosphaeria obtusa is significant, particularly in the grape and apple industries. The fungus can cause substantial yield losses and reduce the quality of the fruit. In addition, the cost of managing the disease can be high.
See also
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian

